上睑下垂
癌症研究
EZH2型
蛋氨酸
甲基化
前列腺癌
化学
抑制器
调节器
基因敲除
PRC2
癌症
封锁
下调和上调
细胞凋亡
细胞生物学
生物
癌细胞
医学
溴尿嘧啶
作者
Shuyan Liu,Dao‐Jing Ming,Yi-Hang Xu,Bing-Hui Li,Minghui Shi,Shu Xi,Jin‐Long Cui,Jiayu Yang,Xi Xiong,Shaohua He,Wang Shi-chun,Dan-Qi Wang,Jia Zhang,Hong Weng,Xian‐Tao Zeng,Shuai Yuan
标识
DOI:10.1073/pnas.2600167123
摘要
EZH2 is frequently overexpressed in solid tumors, yet the clinical efficacy of its inhibitors remains limited, highlighting an urgent need to elucidate their cytotoxic mechanisms. Here, we identify EZH2 as a posttranslational suppressor of pyroptosis through direct methylation of GSDMD. We revealed that EZH2 inhibition triggered GSDMD-dependent pyroptosis in prostate cancer cells. Clinical specimens showed an inverse correlation between EZH2 levels and cleaved GSDMD (GSDMD N-terminal, GSDMD-N) levels, reinforcing its role as a negative regulator of GSDMD activation. Mechanistically, EZH2 methylated GSDMD at lysine 168, thereby blocking caspase-1-mediated cleavage and suppressing its activation. Notably, methionine deprivation overcame this blockade and combined with the EZH2 inhibitor GSK126 to enhance pyroptosis and suppress tumor growth in vivo. These findings establish the methionine-EZH2-GSDMD axis as an epigenetic-metabolic hub controlling pyroptosis via posttranslational regulation, providing a mechanistic rationale for co-targeting methionine metabolism and EZH2 in prostate cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI